newsfilter
← Latest News
PR Newswire·

Inhibrx Announces Participation in Upcoming Investor Conference

SAN DIEGO, Nov. 18, 2022 /PRNewswire/ -- Inhibrx, Inc. (NASDAQ:INBX), a clinical-stage biopharmaceutical company dedicated to the development of therapeutics for oncology and rare diseases, today announced it will be